J591 monoclonal antibody: Clinical Trials

5 trials of J591 monoclonal antibody, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Active not recruiting 1, Completed 1

Follow J591 monoclonal antibody: new trials by email Literature Review of J591 monoclonal antibody trials Research Report on J591 monoclonal antibody

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant J591 Treatment for Prostate Cancer
huJ591, 89Zr-J591 - Prostate Cancer
Phase 1CompletedWeill Medical College of Cornell University82016-02-042020-10-05
J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts
huJ591 - Prostate Cancer
Phase 1CompletedWeill Medical College of Cornell University102015-07-012023-04-06
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
177Lu-J591 - Kidney Cancer, Head and Neck Cancer
Phase 1CompletedWeill Medical College of Cornell University202009-07-012022-02-02
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
177Lu-J591, Ketoconazole, Hydrocortisone - Prostate Cancer
Phase 2Active not recruitingWeill Medical College of Cornell University552009-06-012026-04-08
Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2
Monoclonal Antibody J591, Recombinant Interleukin-2 - Prostatic Neoplasms
Phase 2CompletedBZL Biologics2007-01-22

Conditions studied

Prostatic Neoplasms (4)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Kidney Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Weill Medical College of Cornell University (4)  ·  BZL Biologics (1)

Countries

United States (5)

Top investigators

Scott Tagawa, MD (3)  ·  Scott T Tagawa, M.D. (1)